4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-061814
Chief Commercial Officer bought 900 shares at $5.95 ($5,355)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reiter Sarah Chief Commercial Officer | 2019-12-23 | Purchase | +900 | $5.95 | $5,355 | 3,100 | D |
| Open-market purchases · 900 sh · avg $5.95 · $5,355 | |||||||
Loading xslF345X03/doc4.xml…